EMA's safety committee recommends suspending preterm birth drugs
The European Medicines Agency is taking aim at preterm birth drugs, with the agency’s safety committee recommending that medicines containing 17-hydroxyprogesterone caproate, also known as 17-OHPC, be suspended. A review by the …